Intrauterine transfusion treatment of nonimmune hydrops fetalis secondary to human parvovirus B19 infection.
 Congenital human parvovirus B19 infection presented in this case as nonimmune hydrops fetalis that resulted from aplastic anemia at 20 weeks' gestation.
 Intravascular transfusion therapy led to resolution of the hydrops and a term delivery of an appropriately grown neonate.
